Mike Lawing attended the Kidney Cancer Symposium in Chicago in October 2013, a forum for the top kidney cancer doctors in the world to share ideas. He is preparing a report for the KCA, presenting the highlights of the meeting in patient-approachable language. Meanwhile, he shares his insights from this important meeting.
Five years ago, there were no drugs to combat kidney cancer, and kidney cancer was notoriously unresponsive to classic chemotherapy. Now there is an array of new drugs to help, and there is more hope for people with kidney cancer than ever before.
Mike and Joyce talk about the progress and challenges presented at the KCA's Annual Kidney Cancer Symposium.
Sorry we couldn't complete your registration. Please try again.
You must accept the Terms and conditions to register